Semaglutide reduces the risk of heart attack, stroke, and other major cardiac events. | Drug Discovery And Development ...

A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and ...

Semaglutide appears to be protective against heart attacks and other cardiac events regardless of weight loss, research has ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

The number of medications in development to treat obesity continues to grow, and the drugs can offer health benefits for ...

The cardioprotective effects of semaglutide are independent of baseline adiposity and weight loss, according to a recent study.

Tirzepatide, semaglutide, and liraglutide vs DPP4i were associated with lower risk of alcohol use disorder, especially among men and younger patients.

New clinician-guided program blends medical science, microdosing, and 24/7 support to make advanced weight loss and wellness ...

Some guys are getting this promising new weight loss drug on the grey market. Here's what it does and the risks of taking it ...

The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, to reduce cardiovascular risk in type 2 diabetes ...

In 2023, 48.5 million people ages 12 or older in the U.S. contended with a substance use disorder or disorders -- for almost 29 million, it was an alcohol use disorder (AUD) and around 27 million ...

Hospitalized patients with diabetes require specialized management to reduce readmission rates and complications. Newer ...